Among patients with severe community-acquired pneumonia and high initial inflammatory response, the use of the corticosteroid methylprednisolone decreased treatment failure, compared with placebo, according to a new study.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1ELo5Nz
from Today's Healthcare News -- ScienceDaily http://ift.tt/1ELo5Nz
No comments:
Post a Comment